$110.760
+1.108 (+1.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de HALO por análisis de gráficos similares
Alphio's HALO stock price prediction model matches the current Halozyme Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $110.20 (-0.51%). The 1-week path is $114.86 (+3.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Halozyme Therapeutics Inc?
Halozyme Therapeutics Inc is a good buy right now due to its strong revenue growth and positive earnings outlook. The current price is $105.35, and the company reported a 48% year-over-year revenue increase to $480.99 million in Q2 2026. Additionally, the forward P/E ratio is 14.53, indicating attractive valuation compared to future earnings potential. However, a risk to consider is the significant increase in hedge fund selling, which has risen by 4215.85% over the last quarter, suggesting caution in market sentiment.
HALO cerró en $110.76 el Thursday, tras subir +1.00%
Halozyme Therapeutics Inc (HALO) last closed at $110.76, gaining +1.00%. These facts feed the 1-day and 1-week HALO price prediction above.
Consenso de analistas
Halozyme Therapeutics Inc (HALO): 7 comprar, 2 mantener, 1 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Halozyme Therapeutics Inc (HALO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de HALO, ordenadas por similitud.
Análisis de estacionalidad de HALO
Historically the probability of a positive September return for HALO is 100.00%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de HALO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $80.19 | $83.82 | $89.17 | -24.32% |
| Oct 2026 | $77.26 | $79.18 | $94.61 | -28.51% |
| Nov 2026 | $75.84 | $83.82 | $97.22 | -24.32% |
| Dec 2026 | $68.14 | $78.83 | $80.41 | -28.82% |
En 2026, se proyecta que Halozyme Therapeutics Inc (HALO) oscile entre $68.14 y $97.22.
Previsión mensual de Halozyme Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Halozyme Therapeutics Inc promedie $83.82, con un mínimo de $80.19 y un máximo de $89.17.
En Oct de 2026, se proyecta que Halozyme Therapeutics Inc promedie $79.18, con un mínimo de $77.26 y un máximo de $94.61.
En Nov de 2026, se proyecta que Halozyme Therapeutics Inc promedie $83.82, con un mínimo de $75.84 y un máximo de $97.22.
En Dec de 2026, se proyecta que Halozyme Therapeutics Inc promedie $78.83, con un mínimo de $68.14 y un máximo de $80.41.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.